gold alloy nanoparticles for determination of anticancer drug flutamide

gold alloy nanoparticles for determination of anticancer drug flutamide

Accepted Manuscript A novel luminol chemiluminescent method catalyzed by silver/gold alloy nano‐ particles for determination of anticancer drug flutam...

537KB Sizes 2 Downloads 36 Views

Accepted Manuscript A novel luminol chemiluminescent method catalyzed by silver/gold alloy nano‐ particles for determination of anticancer drug flutamide Mohammad Javad Chaichi, Seyed Naser Azizi, Maryam Heidarpour PII: DOI: Reference:

S1386-1425(13)00808-1 http://dx.doi.org/10.1016/j.saa.2013.07.060 SAA 10804

To appear in:

Spectrochimica Acta Part A: Molecular and Biomo‐ lecular Spectroscopy

Received Date: Revised Date: Accepted Date:

2 March 2013 23 June 2013 22 July 2013

Please cite this article as: M.J. Chaichi, S.N. Azizi, M. Heidarpour, A novel luminol chemiluminescent method catalyzed by silver/gold alloy nanoparticles for determination of anticancer drug flutamide, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy (2013), doi: http://dx.doi.org/10.1016/j.saa.2013.07.060

This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

A novel luminol chemiluminescent method catalyzed by silver/gold alloy nanoparticles for determination of anticancer drug flutamide Mohammad Javad Chaichi, Seyed Naser Azizi and Maryam Heidarpour Faculty of Chemistry, Mazandaran University, Babolsar, Postcode 47416-95447, Iran [email protected] Author E-mail:

Abstract It

was

found

that

silver/gold

alloy

nanoparticles

enhance

the

chemiluminescence (CL) of the luminol–H2O2 system in alkaline solution. The studies of UV–Vis spectra, CL spectra, effects of concentrations luminol, hydrogen peroxide and silver/gold alloy nanoparticles solutions were carried out to explore the CL enhancement mechanism. Flutamide was found to quench the CL signals of the luminol– H2O2 reaction catalyzed by silver/gold alloy nanoparticles, which made it applicable for the determination of flutamide. Under the optimum conditions, the CL intensity is proportional to the concentration of the flutamide in solution over the range 5.0×10−7 to 1.0×10−4mol L-1. Detection limit was obtained 1.2×10−8 mol L-1and the relative standard deviation (RSD)

5%. This work is introduced as a new method

for the determination of flutamide in commercial tablets. Box-Behnken experimental design is applied to investigate and validate the CL measurement parameters. Keywords: Flutamide, Silver/Gold alloy nanoparticles, Luminol, hydrogen peroxide, chemiluminescence

1. Introduction Flutamide, 4-nitro-3-trifluoromethyl-isobutilanilide, is a synthetic antiandrogenic agent devoid of hormonal agonist activity (Fig. 1).It seems to have antiandrogenic specificity only in genitalia organsandrogen-dependent, and it also shows therapeutic use in prostatic cancer [1, 2]. Flutamide is an unusual example of an antiandrogenic drug lacking with a steroidal structure.

 1  

This drug and its primary hydroxy metabolite decrease metabolism of C-19 steroids by the cytochrome P-450 system at the target cells in the secondary sex organ [3]. A survey of literature reveals that there are not many methods for the assay of the drug. The reported methods include polarography [4, 5], voltammetery [6] gas chromatography [7], UV spectrophotometric method [8, 9] and high performance liquid chromatography [10]. The analytical parameters of the previous reported CL methods for the determination of flutamide drugs were summarized in Table 1. < Table 1> Among luminescence techniques, chemiluminescence (CL) is considered as the most sensitive and versatile analytical technique that can be used in the determination of different compounds depending on their participation in different CL systems [11]. CL analysis has advantages such as high sensitivity, easy to use and simple instrumentation, being actively applied for detection of chemical species at ultra-trace levels [12-18]. Though CL has been investigated for years, study of CL was limited to some molecular systems. Recently, nanoparticles reveal remarkable catalytic qualities for a variety of chemical reactions, depending upon their high surface areas, good adsorption characteristics, high activity, and high selectivity [19–24]. For example, Cui et al [25–27] reported that noble metal nanoparticles can enhance the CL of the lucigenin–KI and luminol–H2O2 systems. In these systems, metal nanoparticles can participate in CL reactions as a catalyst, reductant, luminophor, and energy acceptor [28-31]. However, the application of bimetallic nanoparticles as catalysts in luminol chemiluminescence system is rarely used. In the present study, the function of Au/Ag alloy nanoparticles (NPs) in luminol–H2O2 weak CL system has been explored [32]. It was found that Au/Ag nanoparticles could enhance intensely the CL from the reaction between luminol and H2O2. The effects of the reaction conditions such as pH and reagents concentration on the CL intensity was investigated. The UV-Visible spectra, CL spectra were investigated and the CL mechanism has been proposed. Moreover, the influences of flutamide on the luminol– H2O2−Au/Ag alloy nanoparticles CL system were also explored in detail.

2. Experimental 2.1. Reagents and solutions A 10−4 molL−1 stock solution of luminol (3-aminophthalhydrazide) was prepared by dissolving luminol (Fluka,) in 0.1 mol L−1 sodium hydroxide solutions without purification. A stock solution of hydrogen peroxide (30%, v/v, commercially available) was prepared by  2  

appropriate dilution of 30% solution with water. HAuCl4·4H2O (48% w/w), AgNO3, NaBH4, buffer phosphate and polyethylen glycol (PEG) were obtained from Merck (Schuchardt, Germany). All the chemicals and reagents were of analytical grade and used without further purification; the deionized and triple-distilled water was used throughout. Stock solutions of flutamide were prepared at a constant concentration of 2.5×10-3 M in ethanol. An aliquot of stock solution was taken and diluted with ethanol/ 0.04 M BrittonRobinson buffer mixture (20/80) to obtain a final working solution concentration of 1 ×10-4 M. Flutamide (100% Analytical grade) was obtained from Sigma Aldrich (USA) and the commercial tablets of Drogenil (250.0 mg flutamide per tablet) were obtained commercially.

2.2. Apparatus and software A 3030 Jenway pH meter (leeds, UK) was used for pH measurements. Transmission electron microscopy (TEM) images were recorded on a Philips CM10 transmission electron microscope

(Andover,

USA).

Absorption

spectra

were

recorded

using

UV–Vis

spectrophotometer Cecil, CE5501 (Cambridge, UK). The CL light intensity time curve was carried out by a Sirius-tube luminometer (Pforzheim, Germany) with a photomultiplier tube detector. Also, 15 experimental runs (formulation combinations) for optimization of factor levelswere generated and analyzed using MINITAB 13.

2.3. Synthesis of gold–silver alloy Gold–Silver alloy NPs were synthesized by the hydroborate reduction method. In this paper, the solutions of 0.1M PEG was prepared in 25ml of water. Then 2.5 ml of both HAuCl4 and AgNO3 (5mM) was added and sonicated for 30 min in order to homogeneously distribute the metal ions in the solution. Co-reduced by dropwise adding 20 mL of freshly prepare 3.33 mmol/L NaBH4 to the PEG stabilized metal ion solution. The formed gold/silver nanoparticles were stabilized by the PEG. The size and shape of the synthesized nanoparticles were characterized by transmission electron microscope (TEM). Statistical analysis of TEM data revealed that the average diameters of Au–Ag alloy (3: 2) nanoparticles [33, 34] were 14.0 ± 2.0nm.

 3  

2.4. Preparation of standard solutions A series of ten solutions was which prepared containing flutamide concentration ranging between 1×10-4-5×10-7 M ethanol / 0.04 M Britton-Robinson buffer mixture (20/80) at pH 8.0.

2.5. Sample preparation Ten solutions of one tablet (amount declared 250.0 mg flutamide per tablet) were prepared in ethanol, sonicated and diluted to 50 mL. Then, these solutions were centrifuged for 10 min at 4000 rpm. 0.3 mL aliquot of each solution taken and diluted to 50 mL with ethanol/0.04M Britton Robinson buffer mixture (20/80), pH 8.0. The 0.0156 mg flutamide in the sample solution were calculated from a prepared standard calibration plot.

2.6. General procedure Solution A was made by mixing 0.3 mL of luminol (various concentrations), 0.1 mL of phosphate buffer (pH=8.5-10.5) and 50 µl of flutamide (various concentrations). Solution B contained various volumes of hydrogen peroxide 10-4 M and various volumes of NPs 10-4 M (1:2, 2:1, 1:1). Solution A was transferred into glass cell and then 100 µL of solution B was injected in the glass cell, chemiluminescence light intensity- time spectrum was recorded soon after mixing of the solutions. As mentioned above, flutamide was found to quench the CL emission of quinoxaline. Therefore, the concentration of flutamide was determined on the basis of changing the chemiluminescence intensity (ΔIcL). ΔIcL is obtained from the ratio of CL intensities in the absence (I0) and presence (I) of flutamide i.e., ΔIcL= I0 / I

3. Results and discussion 3.1. Optimization of the method In the present study, the 3-level 3-factor Box–Behnken experimental design is applied to investigate and validate CL measurement parameters affecting the CL intensity of Luminol pH / Au/Ag alloy NPs/H2O2 system. The factor levels were coded as: −1 (low), 0 (central point or middle) and 1 (high) [35]. The variables and levels of the Box–Behnken design model are given in Table S1. The results were analyzed using the coefficient of determination (R2), Pareto analysis of variance (ANOVA) and statistical and response plots. A non-linear regression method was used to fit the second order polynomial (Eq. (1)) to the experimental

 4  

data and to identify the relevant model terms. Considering all the linear terms, square terms and linear by linear interaction items, the quadratic response model can be described as Y = β0 +Σβixi +Σβiix2ii +Σβijxixj + ε

(1)

where, βo is the offset term, βi is the slope or linear effect of the input factor xi, βii is the quadratic effect of input factor xi and βij is the linear by linear interaction effect between the input factor xi and xj [36]. 3.2. Optimization of experimental conditions A Box-Behnken design, a full factorial experimental design plus two centered points (Table 3), was used to optimize the pH and concentrations of luminol and ratio of Au/Ag alloy NPs/H2O2. This study showed that the luminol concentrations, ratio of Au/Ag alloy NPs/H2O2 and the quadratic of ratio of NPs/H2O2 were significant factors at 95% confidence interval, having important effects on the response when their values change in the selected region (Table S2).
The function representing the relationship among pH, luminol concentrations and ratio of Au/Ag alloy NPs/H2O2 and the chosen response is: Y= 14.19 + 3.98X1 + 0.847X2 + 1.07X3-0.53X12 – 0.59X22 – 1.36X32 – 0.447X1X2 +0.81X1X3- 1.05 X2X3

According to analysis of variance (Table 3), it was shown that the predictability of the model is at 95% confidence interval. The ANOVA of these responses demonstrated that the model is highly significant as is evident from the value of Fstatistic (the ratio of mean square due to regression to mean square to real error; Fmodel=25.74) and a very low probability value (P= 0.001). The value of probability P>0.05 indicates that the model is considered statistically significant [37]. The non-significant lack-of-fit (more than 0.05) showed that the quadratic model is valid for present study. Non-significant lack-of-fit is good for data fitness in the model.
Therefore, the three factors were simultaneously optimized. Considering the results obtained from the established response surface (Fig. 2), the following optimum values were found: a 1×10-4 M luminal concentration, a ratio 2:1 of Au/Ag alloy NPs/H2O2 (both corresponding to the highest level tested), and a pH 9.5. However, concentrations of 10-4 M of luminol and, the ratio 2:1 of Au/Ag alloy NPs/H2O2 (10-4M) were chosen to be suitable for  5  

the purposes of the study, because higher concentrations of luminol and Au/Ag alloy NPs/H2O2 could produce the saturation of the detector due to the high CL intensity of the blank signal obtained.

3.3. Analytical performance The ratio of the initial CL intensity I0 of luminaol- buffer- Au/Ag alloy NPs/H2O2 system to the CL intensity I at a given concentration of flutamide, I0/I, was proportional to the concentration of flutamide. The flutamide concentration dependence of the CL intensity was coincident to the fluorescence quenching described by a Stern- Volmer equation (Eq.2.): I0/I=1+Ksv [Q]

(2)

Ksv was found to be 22429 (mol-1 L) and this large value provided a sensitive CL detection of flutamide. The Stern–Volmer plots for flutamide is shown in insert Fig. 3. Under the optimized experimental conditions, the relative CL intensity decreased linearly in the concentration range of 1.0×10-4-5.0×10-7 mol L−1 for flutamide (R2 = 0.9981) with detection limit of 1.8×10−9 mol L−1 at S/N ratio of 3. The resulting intensity–time plots are shown in Fig. 3. (Table S3 lists the measured results of the content of flutamide in tablet).
3.4. Mechanism discussion The nanoparticles were primarily characterized by UV–Visible spectroscopy, which has proved to be a very useful technique for the analysis of nanoparticles. In UV–Visible spectrum a strong, broad peak, located between 420 and 440 nm, was observed for Ag/Au alloy NPs prepared using the culture supernatant (Fig.4). The transmission electron micrographs of Ag/Au alloy NPs are represented in Fig. 5. The particle size was found to a range from 12 to 16 nm. The effects of Ag/Au alloy NPs on the chemiluminescent system were investigated. As shown in insert Fig. 4, the CL signal was enhanced by Ag/Au alloy NPs.

 6  

The luminol based CL reaction is a well-known method for the detection of reactive oxygen species, such as O2-, 1O2, and H2O2, because these species react quickly with luminol in alkaline solution to emit light, as the hydroperoxide intermediate of luminol decomposes into aminophthalate. The results (insert Fig.4) showed that the CL signal was enhanced by Ag/Au alloy NPs, indicating that the luminophor in the both CL reactions between luminol and hydrogen peroxide with and without Au/Ag alloy NPs is the same species, which is the oxidation product 3-aminophthalate (3-APA*) of luminol [32].A schematic proposed reaction process could be shown as Scheme 1. 3.5 Application It has been reported that the reducing groups such as OH, NH2, or SH reacted readily with the oxygen-containing intermediate radicals. In the luminol–buffer–Au/Ag alloy NPs/H2O2 system, some intermediate radicals such as HO• and O2•− were formed during the reaction. The reducing groups are likely to compete with luminol for active oxygen intermediates (covered the surface of NPs) leading to a decrease in CL intensity. Therefore, these compounds may interact with Au/Ag alloy NPs to interrupt the formation of luminal radicals (L•−) and superoxide radical anion (O2•−) taking place on the surface of Au/Ag alloy NPs, resulting in a decrease in CL intensity. The results demonstrate that the luminol–buffer– Au/Ag alloy NPs/H2O2 CL system has a wide application for the determination of such compounds via quenching phenomena [32]. Therefore the effects of flutamide on the CL system were investigated. As expected, existence groups NHCO in flutamide as reducing functional groups inhibited the CL signal of luminol–buffer–Au/Ag alloy NPs/H2O2 system. Also the functional groups of NO2 and CF3 are intense electron with drawing groups. Therefore N-H bond is become acidic and the proton may be released easily. Protonation of the excited 3-APA led to quenching of the CL system. Recovery tests were performed to evaluate the accuracy of this method. Results for the contents and recoveries were summarized in Table 4. The recoveries ranged from 98% to 101%, with RSDs of <5.0%.


 7  

3.6. Interferences It is well know that the chemiluminescence reaction is highly sensitive to the external species. Under optimal experimental conditions, the interferences from selected metal ions and organic compounds were evaluated. Most of the candidate compounds had no significant influence on the determination of flutamide concentration. The tolerable molar concentration ratios of foreign species to flutamide were >100 for Na+, K+, Ca+2, Mg+2, NO3- , Cl-, glucose, starch and uric acid ;10 for Fe+2, Cu+2, SO4-2. However, ascorbic acid was found to be strong interfering agents. Ascorbic acid in presence of oxidizing agents led to the quenching effect on luminol CL reaction [38]. 4. Conclusions In conclusion, it was found that Au/Ag alloy NPs could strongly enhance the CL of the luminol–H2O2 system. The mechanism of luminol–H2O2–Au/Ag alloy NPs CL reaction was discussed. The proposed CL system has good linearity, high sensitivity and lower detection limit and the method has been successfully applied to the determination of flutamide in tablet.

References [1]

R.N.

Brogden,

S.P.

Clissold, Drugs 38 (1989) 185-203 [2]

M. Jonler, M. Riehmann, R.C. Bruskewitz, Drugs 47 (1994) 66-81

[3]

A. Osol,J. E. Hoover,Remington’s Pharmaceutical Sciences, XVIII ed. Marck Publishing Co, Easton, PA (1996) 1152-1156

[4]

A. Snycerski, J. Pharm. Biomed. Anal.7 (1989) 1513-1518

[5]

G. V. S. Reddy, C. L. Narayana, V. Myreddy and S.J. Reddy, J. Clinical Medicine and Research 3(3) (2011) 35-39

[6]

P. K. Brahman, R. A. Dar, S. T., Krishna,Colloids and Surfaces A: Physico chem. Eng. Aspects (2012)

[7]

R.T Sane, M.G Gangrade, V.V Bapat, S.R Surve, N.L Chonkar, Indian drugs 30 (1993) 147-151

[8]

K.M. Reddy, K. Suvardhan, K. Suresh, S. Prabhakar, P. Chiranjeevi, Proceedings of the Third International Conference on Environment and Health,Chennai, India 15 (2003) 410-416

 8  

[9]

P. Nagaraja, R H. Arun Kumar, A. Ramanathapura, S. Hemmige. International Journal of Pharmaceutics 325 (2002) 113-123

[10]

A. Smith, R. Manavalan, K. Kannan and N. Rajendiran, International Journal of Pharm Tech Research 1 (2009) 360-364

[11]

A.M. Garc´ıa-Campaña, W.R.G. Baeyens, X. Zhang, in: A.M. Garc´ıa-Campaña, W.R.G. Baeyens (Eds.), Chemiluminescence in Analytical Chemistry, Marcel Dekker, New York (2001)

[12]

P.E. Nicholaos, K.T. Nicholaos, G.V. Athanasios, Talanta 46 (1998) 179-196

[13]

R. Wirat, L. Saisunee, T. Alan, Talanta 69 (2006) 976-983

[14]

Y.H. Li, W.F. Niu, J.R. Lu, Talanta 71 (2007) 1124-1129

[15]

L. H. Zhang, N. Teshima, T. Hasebe, M. Kurihara, T. Kawashima, Talanta 50 (1999) 677-683

[16]

M. Kamil, O. Antonije, M. Pavel, V. Zbynˇek, Talanta 71 (2007) 900-905

[17]

D. Badocco, P. Pastore, G. Favaro, C. Macca, Talanta 72 (2007) 249-255

[18]

B. Denis, P. Paolo, F. Gabriella, M. Carlo, Talanta 72 (2007) 249-255

[19]

L. J. Ottendorfer, Y. A. Gawargious, S. S. M. Hassan, Talanta, 13 (1966) 525-528

[20]

S. F. Li, X. Zhang, Z. Yao, R. Yu, F. Huang, J. Phys Chem C 113 (2009) 1558615592

[21]

Z. F. Zhang, H. Cui, C. Z. Lai, L. J. Liu, Anal Chem 77 (2005) 3324-3329

[22]

S. F. Li, X. Z. Li, J. Xu, X. W. Wei, Talanta 75 (2008) 32-37

[23]

C. F. Duan, H. Cui, Z. F. Zhang, B. Liu, J. Z. Guo, W. Wang, J. Phys Chem C 111 (2007) 4561-4566

[24]

S. F. Li, X. Z. Li, Y.Q. Zhang, F. Huang, F. Wang, W. Wei, Microchim Acta 167 (2009) 103-107

[25]

J. Z. Guo, H. Cui, J. Phys Chem C 111 (2007) 12254-12259

[26]

L. S. Xu, H. Cui , Luminescence 22 (2007) 77-87

[27]

Z. F. Zhang, H. Cui, C.Z. Lai, L.J. Liu, Anal. Chem 77 (2005) 3324-3329

[28]

Z. P. Li, Y. C. Wang, C. H. Liu, Y. K. Li, Anal. Chim. Acta 551 (2005) 85-91

[29]

H. Cui, Z.F. Zhang, M.J. Shi, J. Phys. Chem. B 109 (2005) 3099-3104

[30]

L. Zhang, W. Niu, Z. Li and G. Xu, Chem. Commun.47 (2011) 10353-10355

[31]

L. Zhang, W. Niu, G. Xu, Nano Today 7 (2012) 586-605.

[32]

S. Li , S. Tao, F. Wang, J. Hong, X, Wei, Microchim Acta 169 (2010) 73-78

[33]

S. Harish, R. Sabarinathan, J. Joseph, K. Phani, Materials Chemistry and Physics 127 (2011) 203–207  9  

[34]

H. Cui, J. Zhao Guo, N. Li and L. Jia Liu, J. Phys. Chem. C 112 (2008) 11319-11323

[35]

K.Y. Benyounis, A.G. Olabi, M. S. J. Hashmi, J. Mater. Process. Technol. 164 (2005) 978-982

[36]

M. Evans (Ed.), Optimization of Manufacturing Processes: A Response Surface Approach, Carlton House Terrace, London, (2003).

[37]

M. S. Phadke, Quality Engineering Using Robust Design, Prentice Hall, New Jersey, (1989).

[38]

Y. Zhou, T. Nagaoka, F. Li, G. Zhu, Talanta 48 (1999) 461–467

Figure captions Scheme 1 Possible mechanism for the luminol–Au–Ag alloy NPs– H2O2 colloids CL system Fig. 1. Chemical structure of flutamide Fig. 2.a) Estimated response surface for [pH] =0, b) Estimated response surface for [luminol] =0, c) Estimated response surface for [Au/Ag alloy NPs/H2O2] =0. Fig. 3. Chemiluminescence emission intensity as a function of time for the luminal- bufferAu/Ag alloy NPs/H2O2 system with constant concentration of luminal (10-4M), buffer (pH=9.5) and ratio 2:1 Au/Ag alloy NPs/H2O2 (10-4M) system, and varying concentrations of flutamide: (1) 0.0 (2) 5×10-6 (3) 1.0×10-6 (4) 5×10-5 (5) 1.0× 10-5 (6) 5×10-4 Fig. 4 UV-Vis absorption spectra of gold and gold-silver alloy nanoparticles synthesized by PEG stabilized metal. The inset shows the CL signal was enhanced by Ag/Au alloy NPs (a) luminal- buffer- Au/Ag alloy NPs/H2O2 (b) luminal- buffer-H2O2 systems Fig. 5 TEM image of gold-silver alloy nanoparticles, Particle size distribution of Au/Ag alloy NPs 14.0 ± 2.0nm

Table captions

  10  

Table1. Analytical parameters of the previous CL methods for the determination of flutamide drugs Table 2 Box-Benhken matrix for optimization of chemical factors Table 3 ANOVA results for quadratic equation for CL intensity of flutamide Table 4 Results of flutamide determination and recoveries in tablet sample (n=3)

Supporting information Table S1 Experimental design level of chosen variable Table S2 Test of significance for regression coefficients Table S3 Determination of flutamide in pharmaceutical sample by the proposed method

  11  

H2O2 + OH

_

HO2

_

+

H2O O

O NH OH + NH

_

_

N NH + H2O NH2 O

NH2 O

. O2

_

HO2 Au-Ag alloy nanoparticle H2O2

Au-Ag Catalyst

.

OH

.

OH

+

Au-Ag

O O

_

N N.

_

N NH

NH2 O

NH2 O

CO2

_

+ hv

CO2

_

CO2 N2 +

NH2

CO2 NH2

_

*

_

_

O O2

N N

_

NH2 O

Scheme 1 Possible mechanism for the luminol–Au–Ag alloy NPs– H2O2 colloids CL system

Fig. 1 Chemical structure of flutamide

  12  

a

b

c Fig. 2.a) Estimated response surface for [pH] =0, b) Estimated response surface for [luminol] =0, c) Estimated response surface for [Au/Ag alloy NPs/H2O2] =0.

  13  

Fig. 3. Chemiluminescence emission intensity as a function of time for the luminol- bufferAu/Ag alloy NPs/H2O2 system with constant concentration of luminol (10-4M), buffer (pH=9.5) and ratio 2:1 Au/Ag alloy NPs/H2O2 (10-4M) system, and varying concentrations of flutamide: (1) 0.0 (2) 5×10-6 (3) 1.0×10-6 (4) 5×10-5 (5) 1.0×10-5 (6) 5×10-4

Fig. 4. UV-Vis absorption spectra of gold and gold-silver alloy nanoparticles synthesized by PEG stabilized metal. The inset shows the CL signal was enhanced by Ag/Au alloy NPs (a) luminol- buffer- Au/Ag alloy NPs/H2O2 (b) luminol- buffer-H2O2 systems

  14  

Fig. 5 TEM image of gold-silver alloy nanoparticles, Particle size distribution of Au/Ag alloy NPs 14.0 ± 2.0nm

  15  

Table1. Analytical parameters of the previous CL methods for the determination of flutamide drugs

Method

Linear range

DL

(mol L-1)

(mol L-1)

HPLC with UV detection

3.6×10-7- 2.1×10-6

3.1×10-8

[8]

Flow- Injection method

3.6×10-4-1.4×10-3

4.3×10-7

[48]

spectrophotometric method spectrophotometric method

-6

-5

-6

-5

-9

-5

2.8×10 - 3.6×10 2.9×10 - 5.1×10

Ref.

-7

[8]

-7

[9]

-9

4.7×10 4.6×10

differential pulse polarogrphy

2.0×10 - 1.5×10

1.7×10

[5]

voltammetry

7.2×10-5- 5.7×10-4

1.8×10-7

[6]

This work

5.0×10−7-1.0×10−4

1.2×10−8

-

Table 2. Box-Benhken matrix for optimization of chemical factors Experiment

Luminol

pH

NPs/ H2O2

Experimental

Expected

SE expected

1

0

0

0

13.658

14.199

0.477

2

+

+

0

16.700

17.452

0.715

3

-

-

0

8.5460

7.7940

0.715

4

-

0

-

7.7340

8.0650

0.715

5

0

0

0

14.923

14.199

0.477

6

-

+

0

10.571

10.382

0.715

7

+

0

-

15.018

14.408

0.715

8

0

0

0

14.017

14.199

0.477

9

0

-

-

8.8490

9.2700

0.715

10

-

0

+

7.9760

8.5860

0.715

11

0

-

+

13.375

13.517

0.715

12

0

+

+

13.525

13.104

0.715

13

+

0

+

18.501

18.170

0.715

14

+

-

0

16.463

16.652

0.715

15

0

+

-

13.212

13.070

0.715

  16  

Table 3 ANOVA results for quadratic equation for CL intensity of flutamide Source

DF

Sum of square

Mean square

F-ratio

P

Prob>F

Regression

9

157.925

17.547

25.74

0.001

Significant

Residual error

5

3.409

0.6817

Lack-of-fit

3

2.559

0.8525

2.01

0.350

Not Significant

Pure error

2

0.850

0.4250

Total

14

161.334

Table 4 Results of flutamide determination and recoveries in tablet sample (n=3) Sample Added (10-5 Mol L−1)Found (10-5 Mol L−1)

Recovery (%)

1

0

1.04 ± 0.03

-

2

1

2.03 ± 0.25

99 1.2

3

5

6.10 ± 0.51

4

10

10.84 ± 0.047

101

R.S.D (n=3) (%) -

4.8 98 3.2

  17  

A novel luminol chemiluminescent method catalyzed by silver/gold alloy nanoparticles for determination of anticancer drug flutamide

Mohammad Javad Chaichi*, Seyed NaserAzizi and Maryam Heidarpour

  18  

Highlight A silver/gold alloy nanoparticle is used as catalysis for luminal CL system. Box–Behnken experimental design is used in the CL measurement parameters. The high sensitivity method is developed for determination of flutamide. There is a suitable LOD and LDR for detection of flutamide in tablets.

  19